Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Dri Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence in the United States; European Union; Japan, and Rest of the world.


TSX:DHT.UN - Post by User

Comment by Capharnaumon Jul 08, 2024 2:51pm
141 Views
Post# 36123191

RE:RE:RE:The key part is

RE:RE:RE:The key part is
raybay_98 wrote: "I don't think the chairman would say the financial statements are good unless he were very sure."
Is he saying what he is told or does he really understand financial statments and accounting? With the stock price down 29% it appears the market doesn't buy that story neither! JMHO



On one hand, if the only thing is the CEO getting paid for false expenses, and considering this would have affected past results negatively (but already cooked in), and there's nothing else to it, then they can move on and providing they can put in place a good replacement, should support going back to better share price.

On the other hand, the CEO getting paid for false expenses, with possibly the CFO turning a blind eye to it, could lead to finding other skeletons the CEO burried. This could potentially be bad for shareholders, hold or lower the share price.

The next CC will be interesting for sure and should provide more clarity.
<< Previous
Bullboard Posts
Next >>